| Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19 C Mirabelli, JW Wotring, CJ Zhang, SM McCarty, R Fursmidt, CD Pretto, ... Proceedings of the National Academy of Sciences 118 (36), e2105815118, 2021 | 194 | 2021 |
| Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2 Y Qiao, XM Wang, R Mannan, S Pitchiaya, Y Zhang, JW Wotring, L Xiao, ... Proceedings of the National Academy of Sciences 118 (1), e2021450118, 2021 | 176 | 2021 |
| Discovery and biosynthesis of cyclic plant peptides via autocatalytic cyclases DN Chigumba, LS Mydy, F de Waal, W Li, K Shafiq, JW Wotring, ... Nature Chemical Biology 18 (1), 18-28, 2022 | 38 | 2022 |
| Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern JW Wotring, R Fursmidt, L Ward, JZ Sexton Journal of Dairy Science 105 (4), 2791-2802, 2022 | 37 | 2022 |
| In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs WKB Chan, KM Olson, JW Wotring, JZ Sexton, HA Carlson, JR Traynor Scientific Reports 12 (1), 5320, 2022 | 20 | 2022 |
| Gene-guided discovery and ribosomal biosynthesis of moroidin peptides RD Kersten, LS Mydy, TR Fallon, F de Waal, K Shafiq, JW Wotring, ... Journal of the American Chemical Society 144 (17), 7686-7692, 2022 | 16 | 2022 |
| TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform AL Peiffer, JM Garlick, Y Wu, JW Wotring, S Arora, AS Harmata, ... ACS Medicinal Chemistry Letters 14 (6), 860-866, 2023 | 15 | 2023 |
| Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is required for SARS-CoV-2 infection in circulating monocytes Y Yao, K Subedi, T Liu, N Khalasawi, CD Pretto-Kernahan, JW Wotring, ... Cell Discovery 8 (1), 89, 2022 | 14 | 2022 |
| Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19. bioRxiv. 2020 C Mirabelli, JW Wotring, CJ Zhang, SM McCarty, R Fursmidt, T Frum, ... Preprint, 0 | 13 | |
| ARF6 is a host factor for SARS-CoV-2 infection in vitro C Mirabelli, J Bragazzi Cunha, JW Wotring, EJ Sherman, J El Saghir, ... Journal of General Virology 104 (6), 001868, 2023 | 9 | 2023 |
| Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection Y Qiao, JW Wotring, CJ Zhang, X Jiang, L Xiao, A Watt, D Gattis, ... PloS one 18 (2), e0281281, 2023 | 4 | 2023 |
| Imaging-Based Screening Identifies Modulators of the eIF3 Translation Initiation Factor Complex in Candida albicans K Metzner, MJ O’Meara, B Halligan, JW Wotring, JZ Sexton, TR O’Meara Antimicrobial Agents and Chemotherapy 67 (7), e00503-23, 2023 | 2 | 2023 |
| In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment JW Wotring, SM McCarty, K Shafiq, CJ Zhang, T Nguyen, SR Meyer, ... Vaccines 10 (8), 1284, 2022 | 2 | 2022 |
| Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response Y Qiao, JW Wotring, Y Zheng, CJ Zhang, Y Zhang, X Jiang, CD Pretto, ... Proceedings of the National Academy of Sciences 120 (30), e2221809120, 2023 | 1 | 2023 |
| Circulating monocytes co-expressing surface ACE2 and TMPRSS2 upon TLR4/7/8 activation are susceptible to SARS-CoV-2 infection Y Yao, K Subedi, JZ Sexton, T Liu, N Khalasawi, C Pretto, JW Wotring, ... The Journal of Immunology 208 (1_Supplement), 163.25-163.25, 2022 | 1 | 2022 |
| Inhibition of sars-cov-2 viral entry through oral administration of lactoferrin and uses thereof KJ Weatherwax, C Mirabelli, JZ Sexton, SM McCarty, J Wotring US Patent App. 17/920,698, 2023 | | 2023 |
| High-Content Screening to Identify Inhibitors of Dengue Virus Replication JG Hoffstadt, JW Wotring, S Porter, B Halligan, MJ O’Meara, AW Tai, ... bioRxiv, 2023.03. 24.534108, 2023 | | 2023 |
| RAPID REPURPOSING OF DRUGS FOR NON-ALCOHOLIC FATTY LIVER DISEASE USING HIGH CONTENT IMAGING J Wotring, J Sexton, R Fursmidt HEPATOLOGY 76, S863-S864, 2022 | | 2022 |
| In Vitro Evaluation and Mitigation of Niclosamide Liabilities as a COVID-19 Treatment.(preprint) JW Wotring, SM McCarty, K Shafiq, CJ Zhang, T Nguyen, SR Meyer, ... | | 2022 |
| ARF6 is an important host factor for SARS-CoV-2 infection in vitro (preprint) C Mirabelli, EJ Sherman, JW Wotring, J El Saghir, JB Cunha, J Harder, ... | | 2022 |
